Transplantation of kidneys donated from the USA: Long-term results and viability testing using 31P-MRS

Transplant International

Volumn 10, Issue 1, 1997, Pages 7-12

  Qta, Kazuo ^a   Fuchinoue, Shohei ^a   Nakamura, Michio ^a   Tokumoto, Tadahiko ^a   Tanabe, Kazunari ^a   Toma, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

31P magnetic resonance spectroscopy; Japan; Organ sharing; USA; Viability

Indexed keywords

CREATININE; EURO COLLINS SOLUTION; PHOSPHATE; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; INTERNATIONAL COOPERATION; JAPAN; KIDNEY DONOR; KIDNEY FUNCTION TEST; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGED; CHILD; FEMALE; GRAFT SURVIVAL; HUMANS; JAPAN; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; TISSUE DONORS; UNITED STATES;

EID: 0031060361     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1997.tb00529.x     Document Type: Article

References (14)

1. Alexander JW, Bennett LE, Breen TJ (1994) Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network, for Organ Sharing registry. Transplantation 57: 871-876
2. Berthoux F (1995) Hepatitis C virus infection and disease in renal transplantation. Nephron 71:386-394
3. Bretan PN Jr, Vigneron DB, Hricak H, Juenemann KP, Williams RD, Tanagho E A, James TL (1986) Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion. J Urol 136:1356-1359
4. Duarte R, Huraib S, Said R, AbdelKhadir A, Sullivan S, Chaballout A, Sbeih F, Mughal T (1995) Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis. Am J Kidney Dis 25:40-45
5. Edwards EB (1994) Summary of 1994 report of center-specific graft and patient survival rates. In: Terasaki PI, Cecka JM (eds) Clinical Transplants 1994. UCLA Tissue Typing Laboratory, Los Angeles, pp541-554
6. Fuchinoue S, Teraoka S, Tojimbara T, Nakajima H, Honda H, Ota K (1988) Evaluation of intracellular energy status during liver preservation by 31PNMR spectroscopy. Transplant Proc 55: 953-957
7. Morales JM, Campistol JM, Castellano G, Andres A, Colina F, Fuertes A, Ercilla G, Bruguera M, Andreu J, Carretero P, Rodicio JL, Levey AS, Pereira BJG (1995) Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 47: 236-240
8. Orloff SL, Stempel ÇA, Wright TL, Tomlanovich SJ, Amend WJC, Stock PG, Melzer JS, Vincent! F (1995) Longterm outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplant 9:119-124
9. Ota K (1989) Organ transplantation in Japan - present status and problems. Transpl Int 2: 61-67
10. Ota K, Teraoka S, Kawai T (1995) Current situation of transplantation in Asia: organ transplantation in Japan. Transplant Proc 27:1-3
11. Preuschof L, Lobo C, Offermann G (1991) Role of cold ischemia time and vascular rejection in renal grafts from elderly donors. Transplant Proc 23: 1300-1301
12. UNOS (1993) 1993 Annual report OPTN & scientific registry of transplant recipients
13. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I (1995) Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 60: 642-647
14. Zucker K, Cirocco R, Roth D, Oison L, Burke GW, Nery J, Esquenazl V, Miller J (1994) Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation 57:832-840